Verantwortliche Person under § 52a AMG: the GDP seat behind Germany's wholesale licence

Germany writes a handful of pharma roles directly into law, and this one hides in the least glamorous corner of the industry. Distribution. Warehouses, temperature data, batch traceability, the paperwork of who sold what to whom. Ask a group of pharma professionals about the sachkundige Person under § 14 AMG and most will have a rough idea. Ask who signs off the GDP system at a wholesaler and the room goes quiet.

That gap is worth your attention, because the seat is mandatory, the supply of people who can fill it credibly is thin, and a court ruling in 2020 widened who is allowed in. I write this from 16 years recruiting in pharma, where named statutory responsibility on a CV was reliably the line that separated senior profiles from everyone else.

What the role actually owns

The duties come from two directions. § 52a AMG requires the appointment. Chapter 2 of the EU GDP guidelines describes what the person does, and German supervising authorities read the two together.

In practice the responsible person makes the calls nobody else in a warehouse is allowed to make. Whether a returned pack goes back into saleable stock or gets destroyed. Whether a supplier holds a valid authorisation and may be bought from at all. Whether a customer is entitled to receive prescription medicines. What happens when a temperature excursion is reported from a shipment that has already been delivered. When a recall arrives, this person runs it and answers for its completeness. When a batch shows up that looks falsified, the decision to quarantine and notify sits here too.

Alongside the daily decisions sits the system: the quality management system for distribution, self-inspections, deviation and CAPA handling, qualification of transport routes and service providers, training of warehouse staff, and the contracts that pin down outsourced activities. It is a judgement role with a documentation shadow, and in an inspection it is the seat that gets asked the uncomfortable questions.

The legal basis in brief: § 52a AMG

Four points from the statute matter before you aim at the seat. Wholesale with medicinal products requires a licence under § 52a(1). The application has to name a responsible person who possesses the expertise the activity requires, § 52a(2) no. 3. The authority may refuse the licence if facts suggest that the applicant or that named person lacks the reliability the work demands, § 52a(4) no. 2. And changes are notified to the authority, with an unforeseen change in the person to be reported without delay under § 52a(8).

What the law leaves out is again the interesting part. No prescribed degree, no minimum years, no certificate. Expertise here is an open legal term, assessed by the competent state authority case by case, which in Germany means the responsible Landesbehörde rather than a federal institute.

The 2020 ruling that widened the door

For years some authorities pushed the position that this seat effectively belongs to pharmacists. On 5 November 2020 the Federal Administrative Court decided otherwise in two parallel cases, 3 C 7.19 and 3 C 9.19.

The court held that pharmaceutical knowledge equivalent to formal pharmacy training is not what the statute demands. What the responsible person needs is competence in handling the specific medicines covered by the licence, and that competence can be built through practical work, including work done under guidance. The required expertise is measured against the products actually handled at that site, the type and scope of the wholesale operation, and the duties the person is actually given. The court also noted that standardised quality procedures normally answer the pharmaceutical questions that arise, so the person is not expected to perform independent pharmaceutical risk analyses on their own.

Read that as a careers document and it says something specific. A QA specialist from a logistics provider, a warehouse manager with GDP scars, a pharmaceutical technician who has grown into quality work, all of them can qualify for a named seat that job ads still describe as pharmacist territory. Some authorities remain conservative in practice, so the target market matters, and so does how well you document what you have actually done.

Who appoints one

Demand follows the licence, which makes it structural. Full-line wholesalers and pharmaceutical trading companies need the role. So does every manufacturer that distributes its own products at wholesale level, every parallel importer and short-line trader, and the logistics providers who run pharma warehouses for other companies. Clinical supply depots, veterinary distributors and the medical cannabis trade sit in the same regime. Small operations often combine the seat with a quality management lead or with the head of warehouse. Larger ones separate them and add deputies, because someone has to be reachable when a recall lands on a Friday evening.

The routes in

The most common route runs through quality inside distribution. GDP officer or QA specialist at a wholesaler or 3PL, then deputy to the responsible person, then the appointment. If you are offered the deputy seat, take it. Companies must keep the function covered during absences, and the deputy is the person authorities have already seen.

The second route comes from pharmacy. Pharmacists moving out of community or hospital practice into industry land here often, because the authority conversation is easier and the product knowledge is already there. The third runs through logistics and supply chain, where someone who has spent years on temperature-controlled transport, serialisation and warehouse compliance grows into the quality side. That route is the one the 2020 ruling made defensible.

What a CV has to evidence for this role

Shortlists separate on evidence, not on job titles. Name the product scope you have handled: prescription medicines, narcotics, cold chain, investigational medicinal products, medical devices alongside pharmaceuticals. Name the systems: which ERP or WMS, which deviation and CAPA tooling, which serialisation setup. Put your inspection history in writing, including which authority, which year, and what your part in it was. If you have held the appointment or the deputy appointment, write it with dates, because that is the single line a hiring manager looks for. Applicant tracking systems filter on exactly these terms, which I cover in the guide on the ATS in pharma.

On language: the licence file, the inspection and the correspondence with the Landesbehörde run in German. Solid German is the realistic expectation for this appointment. English alone will not carry it, however good the GDP experience behind it is.

A note on salary

I will not quote a band. What you earn in this seat depends on whether the appointment sits with a quality lead or a warehouse role, whether it covers one site or several, on the product risk profile, and on whether you hold it in-house or as an external mandate for multiple licence holders. A single figure without those variables would mislead you. The direction is reliable: the named appointment pays above the operational GDP work underneath it, and combining it with a quality management lead moves the range up again.

Frequently asked questions

Do you have to be a pharmacist to be the responsible person under § 52a AMG?

No. The Federal Administrative Court ruled on 5 November 2020, in cases 3 C 7.19 and 3 C 9.19, that pharmaceutical knowledge equivalent to formal pharmacy training is not required. What counts is competence in handling the medicines covered by the licence, which can be acquired through practical experience, including experience gained under guidance. Individual authorities still vary in how strictly they assess this.

Is the § 52a AMG responsible person the same as the GDP Responsible Person?

They describe the same function from two legal directions. § 52a AMG creates the German appointment as a condition of the wholesale licence. Chapter 2 of the EU GDP guidelines of 5 November 2013 describes the Responsible Person and the duties attached to the role. German authorities assess the appointment against both.

Can one person cover several companies or sites?

External and multi-site mandates exist and are common in smaller operations, but the authority looks at whether the person can actually fulfil the duties for each licence. Availability, distance and the number of mandates all come into that assessment, so there is no fixed number that is automatically acceptable.

How does this role differ from the sachkundige Person under § 14 AMG?

The sachkundige Person certifies and releases manufactured batches under the manufacturing authorisation. The § 52a responsible person governs what happens to medicines once they move through wholesale distribution. Different licences, different statutory tests, and in mid-sized companies sometimes the same person holding both.

Sources

§ 52a AMG, wholesale distribution of medicinal products (gesetze-im-internet.de, German)
Federal Administrative Court, judgment of 5 November 2020, 3 C 7.19 (German)
Federal Administrative Court, judgment of 5 November 2020, 3 C 9.19 (German)
Guidelines of 5 November 2013 on Good Distribution Practice, 2013/C 343/01 (EUR-Lex)

© 28 July 2026 Andreas Schulz. All rights reserved. This article is career guidance, not legal advice; the statutory text prevails.